Treatment of glioblastoma with thymosin-alpha 1

Details Treatment of glioblastoma with thymosin-alpha 1 Treatment of glioblastoma with thymosin-alpha 1

A - Human Necessities

61

K

A61K 38/00 (2006.01) A61K 31/17 (2006.01) A61K 31/175 (2006.01) A61K 38/22 (2006.01) A61K 45/06 (2006.01)

Patent

CA 2469595

Thymosin-.alpha.1 is used as an adjuvant in combination with carmustine (BCNU) as an effective treatment for malignant glioblastoma.

L'invention concerne la thymosine-.alpha.1 utilisée comme adjuvant en combinaison avec la carmustine (BCNU) pour traiter de façon efficace le glioblastome malin.

Affiliated with

Also associated with

Rating

Treatment of glioblastoma with thymosin-alpha 1 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of glioblastoma with thymosin-alpha 1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of glioblastoma with thymosin-alpha 1 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1872277